Versatile delivery technologies engineered to generate multiple therapeutic and diagnostic products from a shared scientific foundation—maximizing intellectual property value while reducing single-product risk.
Precision-engineered exosomes designed to carry therapeutic cargo directly to their intended target, harnessing the natural biology of extracellular vesicles.
Next-generation lipid nanoparticle technologies optimized for therapeutic delivery and advanced molecular imaging.
Delivery technologies applicable across major therapeutic and diagnostic categories.
BioBridge is actively expanding its intellectual property portfolio through internal innovation, strategic licensing, and collaborative development to build a diversified portfolio of high-value biotechnology assets.
Multiple pipeline opportunities can be developed from shared platform technologies—allowing each scientific advance to generate multiple commercial applications across therapeutics, imaging, and regenerative medicine.
We collaborate with academic institutions, pharmaceutical companies, CDMOs, and research organizations to accelerate development across our platforms.
Start a Conversation